Life expectancy in cancer has increased thanks to new generation treatment methods
Cancer is one of the most common diseases today. However, while taking some precautions reduces the risk of cancer, it also increases the success of treatment with its newly developed methods. Medical Oncology Specialist Prof. Dr. Aziz Yazıcı emphasized that remarkable success has been achieved with new treatment methods and said, “One of the most important developments in cancer treatment in recent years is immunotherapy. This new method was developed on the basis of activating the patient’s immune system to fight cancerous cells. “Immunotherapy, which has been in theory for many years, has now started to take its place in the standard treatment of many cancers.”
Cancer is still the second leading cause of death worldwide. It is also one of the most common diseases. In fact, about 15 million people in the world are diagnosed with cancer every year. Stating that the number of people diagnosed with new cancer in a year in our country is approximately 160 thousand, Prof. Dr. Aziz Yazici gave the following information: “Every year, these numbers increase. However, it is possible to take measures to reduce the risk of cancer. Not using tobacco and alcohol, being protected from ultraviolet rays and radiation, taking precautions and getting vaccinated against infections such as Hepatitis B and C, HIV, human papilloma virus and H. pylori, taking care of a healthy diet and exercising significantly reduce the formation of cancer.”
Thanks to immuno-oncological treatments, life expectancy in cancer is even longer
Patient-focused, promising developments
Chemotherapy is one of the locomotives of treatment in cancer treatment, which is multidisciplinary, that is, in which many branches of science participate in treatment together. And developments in this area also affect the life expectancy of the patient. Today, thanks to the exciting developments in many types of cancer, progress in five-year survival rates and significant prolongation in lifespan are seen.
While aiming to treat cancer by making it a chronic disease with a patient-oriented approach, Prof. Dr. Aziz Yazıcı continues his words as follows: “Cancer is now better known and can be targeted more effectively. As information about side effects increases, life becomes more livable for patients. Recently, rational (targeted) drugs and immunotherapy have started to take more place as an adjunct or alternative to classical chemotherapy in cancer treatment. These new treatments have increased success in treating patients with cancer.”
Targeted drugs prolong survival in eligible patients
Especially in recent years, with the understanding of the molecular structure of cancer better, the understanding of cancer treatment is changing with the frequently talked about targeted therapies, immunotherapy and personalized cancer treatment. Targeted drugs, which are the first product of this understanding and provide an increase in life expectancy by eliminating the side effects of classical chemotherapy drugs, provided significant advantages. The most important handicaps we experienced were the non-selectiveness of classical chemotherapy drugs and the development of long-term resistance to these drugs in the patient.
Thanks to new treatments, cancer death rates have decreased by 22%!
However, with targeted drugs, which we can define as the most important development of the last decade, side effects have decreased considerably, success in treatment has increased, and cancer patients have been able to survive more. With the appropriate disease and the use of targeted drugs when the patient is sick, the disease can be controlled and life expectancy increased significantly compared to conventional chemotherapy. Today, targeted drugs are successfully applied in many types of cancer, especially in breast, bowel, renal cell (kidney) cancers.
The most important development of recent years in the fight against cancer: Immunotherapy
Immunotherapy, which was developed on the basis of activating the patient’s immune system and fighting cancer cells, is shown as one of the most important developments in recent years. Stating that immunotherapy, which has been in theory for many years, has begun to take its place in the standard treatment of many cancers today, Prof. Dr. The author continues his words as follows: “Tumor cells can form in different places in our body every day. Our immune system prevents the development of cancer by destroying these tumor cells.
However, tumor cells can escape from the immune system by deactivating the mechanisms that will recognize themselves in the immune system or by hiding the structures that show their differences on the tumor cell itself. Thus, cancer occurs when tumor cells are not perceived as foreign and begin to live and circulate freely in the body.
Starting from this point, studies have started to correct the disorder in the immune system. Immunotherapy for melanoma was first approved in 2011, and work in this area has gained momentum. In 2016, immunotherapy was approved for lung, kidney, bladder, and head and neck cancers and advanced stages of Hodgkin lymphoma. The trials of these drugs in the treatment of many diseases are increasing day by day.”
Detailed cancer symptoms! Knowing these could save your life
Regarding the side effects of immunotherapy, which provides a treatment option with less side effects and enables them to live longer, especially for advanced cancer patients, Prof. Dr. Aziz Author gives the following information: “The most common side effects are fatigue, decreased appetite, rash and itching. Less frequently, side effects can be seen on the lungs, intestines, liver, kidneys and hormone-producing organs. However, it should not be forgotten that the use of immunotherapy in cancer treatment is still in its infancy and studies are still ongoing.
The importance of preventive treatments and early diagnosis has increased
In addition to new approaches that can treat cancer, preventive treatments and early diagnosis possibilities have gained much greater meaning. A successful outcome can be achieved in early-diagnosed cancer and the disease has reached the point where it can be treated like a chronic disease.
For this reason, he pointed out that the diagnosis can be made early with cancer screening and the success of treatment increases. Dr. Aziz Yazıcı said, “The formation of some cancers can also be prevented by screening. ” says. Noting that the chance of success in the treatment of some cancers with early diagnosis is over 90 percent, Prof. Dr. Aziz Yazıcı said, “While screening is performed for breast, cervical, large intestine and prostate cancers, there is not yet a standard screening method for other cancers. “Liquid biopsy” may be promising for the early diagnosis of common and late-presenting cancer types, he says.